PMID: 6105520Aug 23, 1980Paper

Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men

Lancet
H KeenR Marsden

Abstract

Human insulin synthesised by recombinant DNA technology was compared with highly purified porcine insulin in healthy men. Intracutaneous injection over a wide range of concentrations of both insulins into five subjects gave rise to no local reactions over a 48 h period. The glycaemic response to standard subcutaneous injection at high and low dose levels was measured with both insulins in each of six men. Plasma glucose decrement with the two insulins was similar but human insulin was perhaps slightly more potent than porcine insulin at the low dose, and slightly less so at the high. The glycaemic response to the isulins, each infused intravenously at high and low concentrations for 1 h in a further six subjects, showed a similar trend. Depression of glycaemia with human insulin slightly exceeded that with porcine insulin at the low concentration infusion and fell slightly short of it at the high. Genetically synthesised human insulin seems to be safe and effective in man. Its dose-response relationship may differ from that of porcine insulin.

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D V GoeddelA D Riggs
Jun 1, 1980·Diabetologia·W L Miller, J D Baxter

❮ Previous
Next ❯

Citations

Jul 31, 2012·Advances in Therapy·Joseph M Tibaldi
Jun 6, 2000·Advanced Drug Delivery Reviews·J Brange, A Vølund
May 3, 1984·The New England Journal of Medicine·D C RobbinsA H Rubenstein
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·L M KeeferP De Meyts
Jan 5, 2002·Diabetes Technology & Therapeutics·M K FrohnauerJ H Anderson
Jan 1, 1994·Journal of Ocular Pharmacology·J D BartlettD J Pillion
Apr 1, 1986·Archives of Disease in Childhood·M D HockingM Nattrass
Feb 28, 1981·British Medical Journal
Apr 18, 1981·British Medical Journal·D R OwensR G Newcombe
Jan 30, 1982·British Medical Journal·A E PontiroliG Pozza
Jan 18, 1986·British Medical Journal·J Pickup
Aug 8, 1992·BMJ : British Medical Journal·M EggerA Teuscher
Jan 7, 1999·Drug Development and Industrial Pharmacy·A Trehan, A Ali
Dec 1, 1981·Journal of Clinical and Hospital Pharmacy·A D Wright
Apr 26, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·María Rocío VillegasMaría Vallet-Regí
Apr 15, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Riccardo CandidoEster Romoli
Oct 1, 1983·The British Journal of Dermatology·F M Pope
Dec 22, 2007·Nature Reviews. Drug Discovery·Benjamin LeaderDavid E Golan
Oct 19, 2017·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Carlos Pérez-MedinaWillem J M Mulder
May 30, 2015·Pharmacological Reviews·Miia KovalainenKarl-Heinz Herzig
Apr 26, 2019·Journal of Animal Science and Biotechnology·Guoyao Wu, Fuller W Bazer
Oct 23, 2019·Applied Microbiology and Biotechnology·Ruifeng MaoYefu Wang
Feb 9, 2012·Chemical Society Reviews·Stephan Kontos, Jeffrey A Hubbell
Dec 1, 1983·Australian and New Zealand Journal of Medicine·R G Larkins
Jul 1, 1981·The Journal of Pediatrics·W L Miller
Dec 10, 2014·Molecular Pharmaceutics·Demosthenes P MoralesNorbert O Reich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.